Pathogen-specific Tablets
Pathogen-specific Tablets - Related Videos
02:25
PCR-Based Detection of Foodborne Pathogens from Enriched Fly Samples
0 Views •
2026
Source: Pava-Ripoll, et al. Detection of Foodborne Bacterial Pathogens from Individual Filth Flies. J. Vis. Exp. (2015)This video demonstrates a PCR-based method that amplifies target bacterial DNA from enriched fly samples using pathogen-specific tablets, enabling real-time fluorescence detection and melting curve analysis to confirm the presence of foodborne pathogens in individual insects.
03:45
A Bead-Based Multiplex Immunoassay to Identify Pathogen-Specific Antibodies in Saliva
0 Views •
2025
This video demonstrates a bead-based multiplex immunoassay technique to simultaneously detect antibodies for multiple environmental pathogens in human saliva. Fluorescent beads were coupled to antigens from different pathogens, which were captured using antibodies in the human saliva sample. Upon labeling the antibodies using a fluorescent reporter, the beads were analyzed using flow cytometry to assess the presence of different pathogen-specific antibodies in the saliva.
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
0 Views •
Cited by 11 •
2014
We tested the usability of a tablet-computer-based application (EmoCogMeter) in investigating the effects of age on cognition. Results show an age-related cognitive decline, thereby proving the usability of our application. Findings underline the great clinical and practical potential of a tablet-based application for detection and monitoring of cognitive dysfunction.
12:54
Detection of Foodborne Bacterial Pathogens from Individual Filth Flies
0 Views •
Cited by 20 •
2015
A PCR-based protocol was adapted to detect Cronobacter spp., Salmonella enterica, and Listeria monocytogenes from body surfaces and alimentary canals of individual wild-caught flies. The goal of this protocol is to detect and isolate bacterial pathogens from individual insects collected as part of an environmental sampling program during foodborne outbreak investigations.
10:10
Evaluating Tests of Cognition using a Computerized Touch-Sensitive Tablet, Eye Tracking, and Functional Magnetic Resonance Imaging
0 Views •
2026
A protocol for simultaneous recording of visuomotor behavior and brain activity during standard paper-based cognitive tests using an MRI-compatible tablet and eye-tracking technology alongside functional MRI, towards improving the usage of such tests. Preliminary results are presented from a young healthy adult performing a Trail-Making test.
FAQs
Selection begins with the susceptibility of the causative organism or pathogen group. The active compound should act on a biological process that the target can support, such as cell-wall synthesis, protein production, or nucleic-acid replication. Matching drug activity to pathogen biology helps align treatment with the infectious agent rather than applying the same compound indiscriminately.
These stages determine how the active compound becomes available after oral administration. The tablet must disintegrate and dissolve in the gastrointestinal tract before the compound can be absorbed and reach the body in an active form. Consequently, treatment response depends not only on pathogen susceptibility but also on successful delivery of the selected compound.
The target determines which essential process the active compound can inhibit. Compounds directed at cell-wall synthesis, protein production, or nucleic-acid replication interfere with different aspects of pathogen function. This distinction provides a biological basis for choosing among treatments and for interpreting why compounds directed at different processes may produce different effects against infectious agents.
Their pathogen-focused design provides a framework for studying how treatment selection affects response and resistance. If an infectious agent is less susceptible to the chosen active compound, treatment may be poorly matched to the pathogen. Comparing susceptibility, treatment response, and resistance emergence helps researchers examine the consequences of linking drug activity to pathogen biology.
A conceptual workflow links the infectious agent to an appropriate active compound, considers the compound’s intended biological target, and follows its oral delivery through gastrointestinal disintegration, dissolution, and absorption. Researchers can then relate the compound’s activity to treatment response and examine whether the observed outcome is consistent with the pathogen’s susceptibility.
They are useful when treatment or investigation must account for whether the infectious agent is bacterial, viral, fungal, or parasitic. In these settings, the tablet provides a practical system for examining targeted management, drug delivery, treatment response, and resistance emergence. The approach also connects formulation behavior with the biology of the organism causing infection.